Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
2925-2936
Author(s):
R. A. Adams, C. Schachtrup, D. Davalos, I. Tsigelny and K. Akassoglou
Biologic Agents in the Treatment of Psoriasis
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
193-217
Author(s):
Fabrizio Guarneri, Claudio Guarneri and Biagio Guarneri
Novel Promising Therapeutic Agents in Multiple Sclerosis
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
218-224
Author(s):
Abbas Mirshafiey
Patent Selections
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
1
Page:
242-246
Author(s):
Bentham Science Publishers
Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2916-2926
Author(s):
Carl-Wilhelm Vogel and David C. Fritzinger
Antifungal Therapy Used in Central Nervous System Fungal Infections
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
7
Page:
166-172
Author(s):
Zhirong Yao, Wanqing Liao and Jianying Liang
Tolerance in the Absence of Autoantigen
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
203-210
Author(s):
D. W. Pascual, J. Ochoa-Reparaz, A. Rynda and X. Yang
Efalizumab
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
205-210
Author(s):
Ekin Savk
Biological Markers for Multiple Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
1956-1965
Author(s):
Andreas Lutterotti, Thomas Berger and Markus Reindl
Central Nervous System Manifestations in Systemic Lupus Erythematosus
Journal:
Current Rheumatology Reviews
Volume:
3
Page:
205-214
Author(s):
Simone Appenzeller, Lilian Tereza Lavras Costallat and Fernando Cendes